trial · primary record
MEDI0618
Migraine
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 309 |
| Primary completion | 2027-02 |
| Primary endpoint | Efficacy of repeat doses of MEDI0618 in preventing migraine headaches in patients with episodic migraine |
| Registry ID | NCT06602479 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:08.578Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06602479
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.